Clinical trial
Effect of Fecal Microbiota Transplantation in Irritable Bowel Syndrome (IBS) - a Randomized, Double-blind Placebo Controlled Pilot Study
NCT02788071 is registered in ClinicalTrials.gov with Aleris-Hamlet Hospitaler København as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Fecal Microbiota Transplantation in Irritable Bowel Syndrome (IBS) - a Randomized, Double-blind Placebo Controlled Pilot Study
- Lead sponsor
- Aleris-Hamlet Hospitaler København
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 31, 2016
- Completion date
- July 31, 2017
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.